10x Genomics (TXG) Reports Q3 Loss, Beats Revenue Estimates

10x Genomics (TXG) came out with a quarterly loss of $0.22 per share versus the Zacks Consensus Estimate of a loss of $0.27. This compares to a loss of $0.3 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +18.52%. A quarter ago, it was expected that this life science technology company would post a loss of $0.35 per share when it actually produced earnings of $0.28, delivering a surprise of +180%.Over the last four quarters, t ...